Amplify Weight Loss Drug & Treatment ETF (NYSEARCA:THNR – Get Free Report) was the target of a large growth in short interest in July. As of July 31st, there was short interest totaling 7,900 shares, agrowthof7,800.0% from the July 15th total of 100 shares. Currently,6.1% of the company’s stock are sold short. Based on an average daily volume of 2,800 shares, the days-to-cover ratio is currently 2.8 days. Based on an average daily volume of 2,800 shares, the days-to-cover ratio is currently 2.8 days. Currently,6.1% of the company’s stock are sold short.
Institutional Inflows and Outflows
A hedge fund recently raised its stake in Amplify Weight Loss Drug & Treatment ETF stock. Jane Street Group LLC increased its position in Amplify Weight Loss Drug & Treatment ETF (NYSEARCA:THNR – Free Report) by 62.7% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 23,676 shares of the company’s stock after acquiring an additional 9,123 shares during the quarter. Jane Street Group LLC’s holdings in Amplify Weight Loss Drug & Treatment ETF were worth $534,000 at the end of the most recent quarter.
Amplify Weight Loss Drug & Treatment ETF Trading Up 0.2%
Amplify Weight Loss Drug & Treatment ETF stock opened at $22.55 on Friday. The company has a market capitalization of $2.93 million and a P/E ratio of 24.31. The firm’s fifty day simple moving average is $22.91 and its 200-day simple moving average is $22.26. Amplify Weight Loss Drug & Treatment ETF has a 1-year low of $18.56 and a 1-year high of $28.19.
Amplify Weight Loss Drug & Treatment ETF Company Profile
The Amplify Weight Loss Drug & Treatment ETF (THNR) is an exchange-traded fund that is based on the VettaFi Weight Loss Drug index. The fund tracks a modified market cap-weighted index of companies from developed markets that manufacture and enable GLP-1 agonist pharmaceutical businesses. THNR was launched on May 21, 2024 and is issued by Amplify Investments.
Featured Stories
- Five stocks we like better than Amplify Weight Loss Drug & Treatment ETF
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- How Did Peter Thiel-Backed Crypto Exchange Bullish’s IPO Go?
- What is the Shanghai Stock Exchange Composite Index?
- Mercury Systems Up 27%: Financials Send Investors a Clear Signal
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Deere’s Sell-Off Could Be a Long-Term Buying Chance
Receive News & Ratings for Amplify Weight Loss Drug & Treatment ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amplify Weight Loss Drug & Treatment ETF and related companies with MarketBeat.com's FREE daily email newsletter.
